Pharmacogenomic Profiling in Personalized Therapeutics: Predicting Drug Response in High-Risk Patients with Cardiometabolic Disorders. Med. Int. J. Health Med. Res. [Internet]. 2025 Oct. 1 [cited 2026 Oct. 24];1(01):28-37. Available from: https://research-education.com/index.php/ijhmr/article/view/6